ConductScience.org, home

Paper23933716

On translation of antibody drug conjugates efficacy from mouse experimental tumors to the clinic: a PK/PD approach.

Haddish-Berhane N and 7 others. J Pharmacokinet Pharmacodyn, 2013. Cited by 55 papers, by iCite.

Cite this record

ConductScience Library. On translation of antibody drug conjugates efficacy from mouse experimental tumors to the clinic: a PK/PD approach. Papers, record 23933716. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/23933716

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
On translation of antibody drug conjugates efficacy from mouse experimental tumors to the clinic: a PK/PD approach.
PubMed
Journal
J Pharmacokinet Pharmacodyn
PubMed
Year
2013
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
55
iCite
Relative citation ratio, by iCite
1.54
iCite
Revised in PubMed
2021-10-21
PubMed

Authors8

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Haddish-Berhane NNahor
2Shah DKDhaval K
3Ma DDangshe
4Leal MMauricio
5Gerber HPHans-Peter
6Sapra PPuja
7Barton HAHugh A
8Betts AMAlison M

Source PubMed

Download CSV of authors

Topics15

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
AntibodiesMajor topic
Antineoplastic AgentsMajor topic
ImmunoconjugatesMajor topic
Neoplasms, ExperimentalMajor topic
Ado-Trastuzumab Emtansine
Animals
Antibodies, Monoclonal, Humanized
Cell Line, Tumor
Female
Humans
Maytansine
Mice
Mice, Nude
Trastuzumab
Xenograft Model Antitumor Assays

Source PubMed

Download CSV of topics

References31

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
120424896Modeling the efficacy of trastuzumab-DM1, an antibody drug conjugate, in mice.J Pharmacokinet Pharmacodyn2010https://conductscience.org/library/papers/20424896PubMed
219769391Antibody-drug conjugates: linking cytotoxic payloads to monoclonal antibodies.Bioconjug Chem2010https://conductscience.org/library/papers/19769391PubMed
314519650Clinical predictive value of the in vitro cell line, human xenograft, and mouse allograft preclinical cancer models.Clin Cancer Res2003https://conductscience.org/library/papers/14519650PubMed
417264369Investigation of various growth mechanisms of solid tumour growth within the linear-quadratic model for radiotherapy.Phys Med Biol2007https://conductscience.org/library/papers/17264369PubMed
510367667Efficacy and concentration-response of murine anti-VEGF monoclonal antibody in tumor-bearing mice and extrapolation to humans.Toxicol Pathol1999https://conductscience.org/library/papers/10367667PubMed
615967831Conceptual and practical implications of breast tissue geometry: toward a more effective, less toxic therapy.Oncologist2005https://conductscience.org/library/papers/15967831PubMed
720204473Basic PK/PD principles of drug effects in circular/proliferative systems for disease modelling.J Pharmacokinet Pharmacodyn2010https://conductscience.org/library/papers/20204473PubMed
814871843Predictive pharmacokinetic-pharmacodynamic modeling of tumor growth kinetics in xenograft models after administration of anticancer agents.Cancer Res2004https://conductscience.org/library/papers/14871843PubMed
916417259Enhanced activity of monomethylauristatin F through monoclonal antibody delivery: effects of linker technology on efficacy and toxicity.Bioconjug Chem2006https://conductscience.org/library/papers/16417259PubMed
1018061880The role of mechanism-based pharmacokinetic-pharmacodynamic (PK-PD) modelling in translational research of biologics.Drug Discov Today2007https://conductscience.org/library/papers/18061880PubMed
1112646013Pharmacodynamic modeling of chemotherapeutic effects: application of a transit compartment model to characterize methotrexate effects in vitro.AAPS PharmSci2002https://conductscience.org/library/papers/12646013PubMed
1219837907Interspecies scaling of therapeutic monoclonal antibodies: initial look.J Clin Pharmacol2009https://conductscience.org/library/papers/19837907PubMed
1319896825The minimum anticipated biological effect level (MABEL) for selection of first human dose in clinical trials with monoclonal antibodies.Curr Opin Biotechnol2009https://conductscience.org/library/papers/19896825PubMed
1420421541Phase I study of trastuzumab-DM1, an HER2 antibody-drug conjugate, given every 3 weeks to patients with HER2-positive metastatic breast cancer.J Clin Oncol2010https://conductscience.org/library/papers/20421541PubMed
1520962582Projecting human pharmacokinetics of therapeutic antibodies from nonclinical data: what have we learned?MAbs2011https://conductscience.org/library/papers/20962582PubMed
1615120038Of mice and men: values and liabilities of the athymic nude mouse model in anticancer drug development.Eur J Cancer2004https://conductscience.org/library/papers/15120038PubMed
1719047765Mathematical modeling of liver metastases tumour growth and control with radiotherapy.Phys Med Biol2008https://conductscience.org/library/papers/19047765PubMed
1823151991Bench to bedside translation of antibody drug conjugates using a multiscale mechanistic PK/PD model: a case study with brentuximab-vedotin.J Pharmacokinet Pharmacodyn2012https://conductscience.org/library/papers/23151991PubMed
1912271329A guide to the new ARENA/OLAW IACUC guidebook.Lab Anim (NY)2002https://conductscience.org/library/papers/12271329PubMed
2019902363Comparison of two pharmacodynamic transduction models for the analysis of tumor therapeutic responses in model systems.AAPS J2010https://conductscience.org/library/papers/19902363PubMed

See all 31 referencesDownload CSV of references

Cited by40

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 55 citations.

PMIDTitleJournalYearIn PapersSource
42978398Design to Dose: Integrating Quantitative Insights Across the Antibody Drug Conjugate (ADC) Development Lifecycle.Clin Transl Sci2026https://conductscience.org/library/papers/42978398PubMed
42883992From Dual Targeting to Clinical Validation: A Translational Framework for Bispecific Antibody-Drug Conjugates.Int J Mol Sci2026https://conductscience.org/library/papers/42883992PubMed
41900840Applications of Pharmacometrics in Antibody-Drug Conjugate Development.Pharmaceutics2026https://conductscience.org/library/papers/41900840PubMed
41854808Industry Practices in Monoclonal Antibody Tissue Biodistribution Assessment: An IQ Consortium Cross-Industry Survey of Current Approaches and Emerging Trends.AAPS J2026https://conductscience.org/library/papers/41854808PubMed
41304790Practical Pharmacokinetic-Pharmacodynamic Models in Oncology.Pharmaceutics2025https://conductscience.org/library/papers/41304790PubMed
41184856Antibody-drug conjugates in cancer therapy: current landscape, challenges, and future directions.Mol Cancer2025https://conductscience.org/library/papers/41184856PubMed
41145622Quantitative systems toxicology: modelling to mechanistically understand and predict drug safety.Nat Rev Drug Discov2026https://conductscience.org/library/papers/41145622PubMed
38532525Quantitative evaluation of trastuzumab deruxtecan pharmacokinetics and pharmacodynamics in mouse models of varying degrees of HER2 expression.CPT Pharmacometrics Syst Pharmacol2024https://conductscience.org/library/papers/38532525PubMed
37787918Towards a platform quantitative systems pharmacology (QSP) model for preclinical to clinical translation of antibody drug conjugates (ADCs).J Pharmacokinet Pharmacodyn2024https://conductscience.org/library/papers/37787918PubMed
37408311Therapeutic index improvement of antibody-drug conjugates.MAbs2023https://conductscience.org/library/papers/37408311PubMed
37380821A PKPD Case Study: Achieving Clinically Relevant Exposures of AZD5991 in Oncology Mouse Models.AAPS J2023https://conductscience.org/library/papers/37380821PubMed
37259689Translation of the efficacy of antibody-drug conjugates from preclinical to clinical using a semimechanistic PK/PD model: A case study with RC88.Clin Transl Sci2023https://conductscience.org/library/papers/37259689PubMed
37111619Pharmacokinetics and Pharmacodynamics of Antibody-Drug Conjugates Administered via Subcutaneous and Intratumoral Routes.Pharmaceutics2023https://conductscience.org/library/papers/37111619PubMed
35806163Theranostic Small-Molecule Prodrug Conjugates for Targeted Delivery and Controlled Release of Toll-like Receptor 7 Agonists.Int J Mol Sci2022https://conductscience.org/library/papers/35806163PubMed
35712824Development of and insights from systems pharmacology models of antibody-drug conjugates.CPT Pharmacometrics Syst Pharmacol2022https://conductscience.org/library/papers/35712824PubMed
35439371Quantitative systems pharmacology modeling provides insight into inter-mouse variability of Anti-CTLA4 response.CPT Pharmacometrics Syst Pharmacol2022https://conductscience.org/library/papers/35439371PubMed
35024323Target-responsive subcellular catabolism analysis for early-stage antibody-drug conjugates screening and assessment.Acta Pharm Sin B2021https://conductscience.org/library/papers/35024323PubMed
34530672Allometric scaling of therapeutic monoclonal antibodies in preclinical and clinical settings.MAbs2021https://conductscience.org/library/papers/34530672PubMed
33922017The Use of Translational Modelling and Simulation to Develop Immunomodulatory Therapy as an Adjunct to Antibiotic Treatment in the Context of Pneumonia.Pharmaceutics2021https://conductscience.org/library/papers/33922017PubMed
32710210Use of translational modeling and simulation for quantitative comparison of PF-06804103, a new generation HER2 ADC, with Trastuzumab-DM1.J Pharmacokinet Pharmacodyn2020https://conductscience.org/library/papers/32710210PubMed

See all 40 cited byDownload CSV of cited by

Genes1

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn Genes
TPBG7162PubTator's text mininghttps://conductscience.org/library/genes/7162

Source NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/23933716

GET https://conductscience.org/api/papers/v1/23933716/references?page=2